within Pharmacolibrary.Drugs.C_CardiovascularSystem.C05C_CapillaryStabilizingAgents.C05CX02_Naftazone;
model Naftazone 
   extends Pharmacolibrary.Drugs.ATC.C.C05CX02;

  annotation(Documentation(
    info ="<html><body><p>Naftazone is a vasoactive drug formerly used for the treatment of peripheral vascular diseases, including chronic venous insufficiency and hemorrhoids, mainly in some European and Asian countries. It is a derivative of naphthoquinone. The use of naftazone has declined and it is not widely approved or available in many markets today.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic parameters for naftazone were identified in literature databases. The following are estimated parameters for a typical adult after oral administration.</p><h4>References</h4><ol><li><p>Delwaide, PA, et al., &amp; Heusghem, C (1974). [The pharmacokinetics of naftazone-3H]. <i>Archives internationales de pharmacodynamie et de therapie</i> 208(2) 357â€“361. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/4849939/&quot;>https://pubmed.ncbi.nlm.nih.gov/4849939</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Naftazone;
